FindTrial
Sign In

Development of Rhinitis, Ezcema and Asthma in allergic March

Development of Rhinitis, Ezcema and Asthma in allergic March

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007041
Enrollment
300
Registered
2022-02-24
Start date
2014-09-22
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - AD patients diagnosed according to the Hanifin and Rajka criteria and with SCORing Atopic Dermatitis (SCORAD) >15 - Ever enrolled on Samsung Medical Center at age of 0-2 years living in Seoul Metropolitan Area

Exclusion criteria

Exclusion criteria: Patients with no symptom and no treatment of drugs within last 6 months

Design outcomes

Primary

MeasureTime frame
Atopic Dermatitis, Asthma, Allergic rhinitis—

Secondary

MeasureTime frame
food allergy, allergen sensitization—

Countries

Korea, Republic of

Contacts

Public ContactYoungmin Kim

Samsung Medical Center

ymkim0218@gmail.com+82-2-3410-3636

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026